Antioxidants and Cardiovascular Disease

Halliwell B. Gutteridge J. M. C. Free radicals in biology and medicine. Oxford: Clarendon Press, 1985.

Babior B. M. Oxygen dependent microbial killing by phagocytes. N Engl J Med 1979; 298: 659–68.

Rice-Evans C. Bruckdorfer K. R. Free radicals, lipoproteins and cardiovascular dysfunction. Mol Aspects Med 1992; 13: 1–111.

Brown M S Goldstein J. L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34–47.

The Lipid Research Clinics Coronary Primary Prevention Trial. Primary prevention trial results. I. Reduction in the incidence of coronary heart disease. J Am Clin Med 1984; 251: 351–64.

Esterbauer H. Dieber-Rotheneder M. Waeg G. Striegl G. Jurgens G. Biochemical, structural and functional properties of oxidised low-density lipoproteins. Chem Res Toxicol 1990; 3: 77–91.

Wolf A. Saito T. Menon N K Zehetgruber M. Bing R. J. Effect of lysophosphatidylcholine on atherosclerotic rabbit arteries. Atherosclerosis 1989; 80: 81–89.

Kodama T. Freeman M. Rohrer L. Zabrecky J. Matsudaira P. Krieger M. Type 1 macrophage scavenger receptor contins α-helical and collagen-like coiled coils. Nature 1990; 343: 531–35.

Steinberg D. Parthasarathy S. Carew T E Khoo J C Witztum J. L. Beyond cholesterol. Modifications of low-density lipoproteins that increase its atherogenicity. N Engl J Med 1989; 320: 915–24.

Smith C. Mitchinson M J Aruoma O I Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of atherosclerotic lesions. Biochem J 1992; 286: 901–905.

Chisolm G M Irwin K C Penn M. S. Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 1992; 41: 61–66.

Esterbauer H. Rotheneder M. Striegl G. . Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat Sci Technol 1989; 91: 316–24.

Steinberg D. Modified forms of low-density lipoprotein and atherosclerosis. J Intern Med 1993; 233: 227–32.

Steinberg D. Witztum J. L. Lipoproteins and atherogenesis – current concepts. JAMA 1990; 264: 3047–52.

Vijayagopal P. Srinivasan S R Radhakrishnamurthy B. Berenson G. Human monocyte-derived macrophages bind low-density lipoprotein–proteoglycan complexes by a receptor different from the low-density lipoprotein receptor. Biochem J 1993; 289: 837–44.

Frostegard J. Nilsson J. Haegerstrand A. Hamsten A. Wigzell H. Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 1990; 87: 904–908.

Quinn M T Parthasarathy S. Fong L G Steinberg D. Oxidatively modified low-density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherosclerosis. Proc Natl Acad Sci USA 1987; 84: 7725–29.

Drake T A Hannani K. Fei H H Lavi S. Berliner J. A. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol 1991; 138: 601–607.

Andrews H A Bruckdorfer K R Dunn R C Jacobs M. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature 1987; 327: 237–39.

Jacobs M. Plane F. Bruckdorfer K. R. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br J Pharmacol 1990; 100: 21–26.

Vita J A Teasure C B Nabel E G . Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491–97.

Vita J A Treasure C B Yeung A C . Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 1992; 85: 1390–97.

Luscher T F Tanner F C Tschudi M R Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med 1993; 44: 395–418.

Herttuala Yla S. Palinski W. Rosenfeld M E . Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989; 84: 1086–95.

Rosenfeld M E Palinski W. Ylaherttuala S. Butler S. Witztum J. L. Distribution of oxidation specific lipid–protein adducts and apolipoprotein-B atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 1990; 10: 336–49.

Mitchinson M J Ball R Y Carpenter K L H Parums D. V. Macrophages and ceroid in atherosclerosis. In: Suckling K E Groot P E eds. Hyperlipidaemias and atherosclerosis. London: Academic Press, 1988: 117–34.

Salonen J T Yla-Herttuala S. Yamamoto R. . Autoantibody against oxidisd LDL and progression of carotid atherosclerosis. Lancet 1992; 339: 883–87.

Davis S W Datta V K Balcon R. Rice-Evans C A Bruckdorfer K. R. Rapid oxidation of plasma low density lipoprotein in coronary heart disease. Br Heart J 1991; 66: 78.

Regnstrom J. Nilsson J. Tornvall P. Landou C. Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183–86.

Meraji S. Moore C E Skinner V O Bruckdorfer K. R. The importance of oxidation and glycosylation of low-density lipoproteins in relation to platelet activation. Platelets 1992; 3: 155–62.

Salonen J T Salonen R. Seppanen K. . Effects of antioxidant supplementation on platelet function: A randomized pair-matched, placebo-controlled, double-blind trial in men of low antioxidant status. Am J Clin Nutr 1991; 53: 1222–29.

Nagano Y. Nakamura T. Matsuzawa Y. Cho M. Ueda Y. Kita T. Probucol and atherosclerosis in the Watanabe Heritable Hyperlipidaemic rabbit – long term anti-atherogenic effect and the effects on established plaques. Atherosclerosis 1992; 93: 131–40.

Dieber-Rotheneder M. Puhl H. Waeg G. Striegl G. Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991; 32: 1325–32.

Jialal I. Grundy S. M. Influence of antioxidant vitamins on LDL oxidation. Ann N Y Acad Sci 1992; 669: 237–47.

Princen H M G Vanpoppel G. Vogelezang C. Buytenhek R. Kok F. J. supplementation with vitamin-E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro – effect of cigarette smoking. Arterioscler Thromb 1992; 12: 554–62.

Bowry V W Stanley K K Stocker R. High density lipoprotein is a major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA 1992; 89: 10316–320.

Steinberg D. Antioxidants in the prevention of human atherosclerosis. Circulation 1992; 85: 2338–44.

Chirico S. Halliwell B. Lipid peroxidation: Its mechanism, measurement and significance. Am J Clin Nutr 1993; 57 (suppl): 715S–25S.

Salonen J T Salonen R. Penttila I. . Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 1985; 56: 1226–31.

Kok F J De Bruijn A M Vermeeren R. . Serum selenium, vitamin antioxidants, and cardiovascular mortality: A 9 year follow-up study in the Netherlands. Am J Clin Nutr 1987; 45: 462–68.

Riemersma R. A. Dietary fatty acids and antioxidant vitamins and the risk of coronary heart disease: The Scottish experience. Acta Cardiol 1989; 44: 482–83.

Riemersma R A Wood D A MacIntyre C C Elton R. Gey K F Oliver M. F. Low plasma vitamins E and C. Increased risk of angina in Scottish men. Ann N Y Acad Sci 1989; 570: 291–95.

Frei B. Stocker R. England L. Ames B. N. Ascorbate: The most effective antioxidant in human blood plasma. Adv Exp Med Biol 1990; 264: 155–63.

Retsky K L Freeman M W Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Antirather than pro-oxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem 1993; 268: 1304–309.

Hunt J V Bottoms M A Mitchinson M. J. Ascorbic acid oxidation: A potential cause of elevated severity of atherosclerosis in diabetes mellitus? FEBS Lett 1992; 311: 161–64.

Ginter E. Decline in coronary mortality in United States and vitamin C. Am J Clin Nutr 1979; 32: 511–12.

Gey F. Puska P. Jordan P. Moser U. K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991; 53: 326–34S.

Stampfer M J Hennekens C H Manson J E Colditz G A Rosner B. Willett W. C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444–49.

Rimm E B Stampfer M J Ascerio A. Giovannucci E. Colditz G. Willett W. E. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450–56.

Gaziano J M Manson J E Ridker P M Buring J E Hennekens C. H. β-carotene therapy for chronic stable angina. Circulation 1990; 82 (suppl III): 201.

Esterbauer H. Gebicki J. Puhl H. Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13: 341–90.

Bendich A. Antioxidant micronutrients and immune responses. Ann N Y Acad Sci 1990; 587: 168–80.

Gaziano J M Manson J E Buring J E Hennekens C. Dietary antioxidants and cardiovascular disease. Ann N Y Acad Sci 1992; 669: 249–58.

Steinberg D. Antioxidant vitamins and coronary heart disease. N Engl J Med 1993; 328: 1487–89.

Weglicki W B Mak I T Simic M. G. Mechanisms of cardiovascular drugs as antioxidants. J Mol Cell Cardiol 1990; 22: 1199–208.

Hertog M G L Feskens E J M Hollman P C H Katan M B Kromhout D. Dietary antioxidant flavonoids and risk from cardiovascular disease: The Zutphen elderly study. Lancet 1993; 342: 107–11.

Frankel E N Kanner J. German J B Parks E. Kinsella J. E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454–57.